Pelicans say Zion Williamson (hamstring) to miss at least two more weeks
Nov 3, 2024; New Orleans, Louisiana, USA; New Orleans Pelicans forward Zion Williamson (1) during warmups before the game against the Atlanta Hawks at Smoothie King Center. Mandatory Credit: Stephen Lew-Imagn Images The New Orleans Pelicans will be without Zion Williamson for at least two more weeks, the team announced Wednesday
Williamson has been out of the lineup since Nov. 6 due to a left hamstring injury. He's played in just six games this season, averaging 22.7 points, 8.0 rebounds and 5.3 assists.
New Orleans selected Williamson No. 1 overall in the 2019 NBA Draft. His time with the Pelicans has been marked by multiple injuries, starting with a torn meniscus during the preseason of his rookie year.
The 6-foot-6, 284-pound forward has played in 190 of a possible 401 regular-season games since the Pelicans drafted him. He appeared in a career-high 70 games last season and averaged 22.9 points, 5.8 rebounds and 5.0 assists per game.
Williamson last played against the Cleveland Cavaliers. New Orleans lost 131-122 despite Williamson posting 29 points, tied for a game-high, as well as eight rebounds and four assists.
The Pelicans are 1-12 without Williamson so far and sit last in the Western Conference at 4-18 overall entering Wednesday's action.
--Field Level Media
WNBA Overreacted to Angel Reese and Paige Bueckers’ $400 Bet
Ohio State Reloads for 2026 With Brutal Schedule Ahead
Vita Vea Requests Trade, and the Rams Make Too Much Sense
WNBA Picks Tuesday: Best Bets for Lynx, Fever and Aces
- MLB Best Bets for Sunday's Rockies vs. Brewers, Yankees vs. Phillies
- UFC Abu Dhabi Best Bets: Top Picks for Ankalaev vs. Guskov Fight Night
- WNBA All-Star Weekend Best Bets: Caitlin Clark, Marina Mabrey and More
- MLB Player Props Today: Best Bets for Wednesday, July 22
- WNBA Best Bets: Wednesday Picks Featuring Lynx, Aces and Wings
- Twins vs. Guardians Prediction: Best Bets for Tuesday's AL Central Showdown
- MLB Best Bets: Jacob Misiorowski, Dylan Cease Lead Monday's Top Picks

